

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | surfactant homeostasis (GO:0043129) | 5.52201842 |
| 2 | glucocorticoid biosynthetic process (GO:0006704) | 5.20017709 |
| 3 | hemidesmosome assembly (GO:0031581) | 4.72404276 |
| 4 | regulation of transforming growth factor beta2 production (GO:0032909) | 4.43814495 |
| 5 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 4.39934721 |
| 6 | regulation of cardioblast differentiation (GO:0051890) | 4.38344509 |
| 7 | fibroblast migration (GO:0010761) | 4.37574154 |
| 8 | chemical homeostasis within a tissue (GO:0048875) | 4.33146183 |
| 9 | negative regulation of fibrinolysis (GO:0051918) | 4.00274558 |
| 10 | glucocorticoid metabolic process (GO:0008211) | 3.99830089 |
| 11 | glomerular filtration (GO:0003094) | 3.89603012 |
| 12 | positive regulation of astrocyte differentiation (GO:0048711) | 3.87794673 |
| 13 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 3.84532932 |
| 14 | protein carboxylation (GO:0018214) | 3.84084636 |
| 15 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.84084636 |
| 16 | complement activation, alternative pathway (GO:0006957) | 3.77387745 |
| 17 | regulation of fibrinolysis (GO:0051917) | 3.71847070 |
| 18 | adhesion of symbiont to host (GO:0044406) | 3.70476823 |
| 19 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.69802781 |
| 20 | L-phenylalanine catabolic process (GO:0006559) | 3.69802781 |
| 21 | endothelial cell chemotaxis (GO:0035767) | 3.69612132 |
| 22 | negative regulation of catenin import into nucleus (GO:0035414) | 3.65788889 |
| 23 | amyloid precursor protein catabolic process (GO:0042987) | 3.65742842 |
| 24 | regulation of protein activation cascade (GO:2000257) | 3.64018068 |
| 25 | epoxygenase P450 pathway (GO:0019373) | 3.58275451 |
| 26 | atrioventricular valve morphogenesis (GO:0003181) | 3.58133011 |
| 27 | regulation of complement activation (GO:0030449) | 3.55127895 |
| 28 | lymphangiogenesis (GO:0001946) | 3.54843857 |
| 29 | mesodermal cell differentiation (GO:0048333) | 3.53714974 |
| 30 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.51851424 |
| 31 | L-phenylalanine metabolic process (GO:0006558) | 3.51554598 |
| 32 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.51554598 |
| 33 | aromatic amino acid family catabolic process (GO:0009074) | 3.48622732 |
| 34 | cell adhesion mediated by integrin (GO:0033627) | 3.46172015 |
| 35 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.42453986 |
| 36 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 3.40605494 |
| 37 | actin filament depolymerization (GO:0030042) | 3.39441029 |
| 38 | sulfur amino acid catabolic process (GO:0000098) | 3.36633904 |
| 39 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 3.36247142 |
| 40 | fibrinolysis (GO:0042730) | 3.34794317 |
| 41 | tryptophan catabolic process (GO:0006569) | 3.31994537 |
| 42 | indole-containing compound catabolic process (GO:0042436) | 3.31994537 |
| 43 | indolalkylamine catabolic process (GO:0046218) | 3.31994537 |
| 44 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.29289890 |
| 45 | cysteine metabolic process (GO:0006534) | 3.29006517 |
| 46 | endothelium development (GO:0003158) | 3.28460539 |
| 47 | sexual reproduction (GO:0019953) | 3.26138589 |
| 48 | cellular response to gonadotropin stimulus (GO:0071371) | 3.20646855 |
| 49 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.19451007 |
| 50 | high-density lipoprotein particle remodeling (GO:0034375) | 3.17879820 |
| 51 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.16477835 |
| 52 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.13899488 |
| 53 | glomerular visceral epithelial cell development (GO:0072015) | 3.13507065 |
| 54 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.12380177 |
| 55 | kynurenine metabolic process (GO:0070189) | 3.12340767 |
| 56 | endocrine hormone secretion (GO:0060986) | 3.12276345 |
| 57 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 3.10606922 |
| 58 | tryptophan metabolic process (GO:0006568) | 3.07830072 |
| 59 | androgen biosynthetic process (GO:0006702) | 3.07670975 |
| 60 | desmosome organization (GO:0002934) | 3.04835855 |
| 61 | homocysteine metabolic process (GO:0050667) | 3.04351028 |
| 62 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.04254446 |
| 63 | response to hepatocyte growth factor (GO:0035728) | 3.04254446 |
| 64 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.03942166 |
| 65 | alpha-linolenic acid metabolic process (GO:0036109) | 3.02064168 |
| 66 | urea cycle (GO:0000050) | 3.01581098 |
| 67 | urea metabolic process (GO:0019627) | 3.01581098 |
| 68 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.99570957 |
| 69 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.98910773 |
| 70 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 2.98030411 |
| 71 | lung vasculature development (GO:0060426) | 2.95953894 |
| 72 | vitamin A metabolic process (GO:0006776) | 2.95575113 |
| 73 | bile acid biosynthetic process (GO:0006699) | 2.93061388 |
| 74 | regulation of endothelial cell differentiation (GO:0045601) | 2.92653402 |
| 75 | cellular response to reactive nitrogen species (GO:1902170) | 2.89421652 |
| 76 | glomerular epithelial cell development (GO:0072310) | 2.89286425 |
| 77 | growth hormone secretion (GO:0030252) | 2.88974563 |
| 78 | reverse cholesterol transport (GO:0043691) | 2.85867475 |
| 79 | endothelial cell proliferation (GO:0001935) | 2.83777426 |
| 80 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.83562573 |
| 81 | lymph vessel development (GO:0001945) | 2.82224947 |
| 82 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.81954927 |
| 83 | negative regulation of blood coagulation (GO:0030195) | 2.80685301 |
| 84 | negative regulation of hemostasis (GO:1900047) | 2.80685301 |
| 85 | ethanol oxidation (GO:0006069) | 2.79651543 |
| 86 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.79246242 |
| 87 | epithelial cell-cell adhesion (GO:0090136) | 2.78676169 |
| 88 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.77702287 |
| 89 | regulation of triglyceride catabolic process (GO:0010896) | 2.75119810 |
| 90 | metanephric nephron epithelium development (GO:0072243) | 2.75036148 |
| 91 | response to follicle-stimulating hormone (GO:0032354) | 2.74501500 |
| 92 | omega-hydroxylase P450 pathway (GO:0097267) | 2.74136179 |
| 93 | peptide catabolic process (GO:0043171) | 2.73253926 |
| 94 | positive regulation of receptor recycling (GO:0001921) | 2.72516064 |
| 95 | semaphorin-plexin signaling pathway (GO:0071526) | 2.72475546 |
| 96 | complement activation, classical pathway (GO:0006958) | 2.72154211 |
| 97 | lung lobe morphogenesis (GO:0060463) | 2.71907399 |
| 98 | bile acid and bile salt transport (GO:0015721) | 2.71769161 |
| 99 | plasma lipoprotein particle clearance (GO:0034381) | 2.71034396 |
| 100 | drug catabolic process (GO:0042737) | 2.70978249 |
| 101 | regulation of plasminogen activation (GO:0010755) | 2.70645382 |
| 102 | glomerular basement membrane development (GO:0032836) | 2.70498280 |
| 103 | embryonic process involved in female pregnancy (GO:0060136) | 2.69867850 |
| 104 | regulation of cholesterol homeostasis (GO:2000188) | 2.69861669 |
| 105 | nitrogen cycle metabolic process (GO:0071941) | 2.69304316 |
| 106 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.68986439 |
| 107 | cellular response to nitric oxide (GO:0071732) | 2.68758168 |
| 108 | positive regulation of blood coagulation (GO:0030194) | 2.68407169 |
| 109 | positive regulation of hemostasis (GO:1900048) | 2.68407169 |
| 110 | vasculature development (GO:0001944) | 2.68088066 |
| 111 | regulation of bile acid biosynthetic process (GO:0070857) | 2.67782303 |
| 112 | outflow tract septum morphogenesis (GO:0003148) | 2.67182780 |
| 113 | renal filtration (GO:0097205) | 2.66703598 |
| 114 | positive regulation of protein kinase C signaling (GO:0090037) | 2.65933431 |
| 115 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.65547128 |
| 116 | negative regulation of coagulation (GO:0050819) | 2.65156019 |
| 117 | phospholipid efflux (GO:0033700) | 2.63802133 |
| 118 | negative regulation of lipase activity (GO:0060192) | 2.63569649 |
| 119 | basement membrane organization (GO:0071711) | 2.63080210 |
| 120 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.62991145 |
| 121 | acylglycerol homeostasis (GO:0055090) | 2.62814510 |
| 122 | triglyceride homeostasis (GO:0070328) | 2.62814510 |
| 123 | positive regulation of digestive system process (GO:0060456) | 2.60759827 |
| 124 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.60396916 |
| 125 | response to nitrosative stress (GO:0051409) | 2.59806163 |
| 126 | amino-acid betaine metabolic process (GO:0006577) | 2.58583629 |
| 127 | cellular glucuronidation (GO:0052695) | 2.58267153 |
| 128 | negative regulation of wound healing (GO:0061045) | 2.57563943 |
| 129 | regulation of p38MAPK cascade (GO:1900744) | 2.56935204 |
| 130 | protein-lipid complex remodeling (GO:0034368) | 2.56810784 |
| 131 | macromolecular complex remodeling (GO:0034367) | 2.56810784 |
| 132 | plasma lipoprotein particle remodeling (GO:0034369) | 2.56810784 |
| 133 | hormone catabolic process (GO:0042447) | 2.56628237 |
| 134 | response to gonadotropin (GO:0034698) | 2.55576746 |
| 135 | cholesterol efflux (GO:0033344) | 2.55497197 |
| 136 | glyoxylate metabolic process (GO:0046487) | 2.55355634 |
| 137 | bile acid metabolic process (GO:0008206) | 2.55096558 |
| 138 | regulation of tight junction assembly (GO:2000810) | 2.54696127 |
| 139 | cell volume homeostasis (GO:0006884) | 2.54511349 |
| 140 | pattern specification involved in kidney development (GO:0061004) | 2.54171159 |
| 141 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.54047811 |
| 142 | positive regulation of coagulation (GO:0050820) | 2.52422233 |
| 143 | metanephric epithelium development (GO:0072207) | 2.52092193 |
| 144 | low-density lipoprotein particle clearance (GO:0034383) | 2.50697136 |
| 145 | cholesterol homeostasis (GO:0042632) | 2.50116153 |
| 146 | sterol homeostasis (GO:0055092) | 2.49471360 |
| 147 | extracellular fibril organization (GO:0043206) | 2.47959609 |
| 148 | cell-substrate junction assembly (GO:0007044) | 2.47209284 |
| 149 | adherens junction assembly (GO:0034333) | 2.47187831 |
| 150 | blood vessel endothelial cell migration (GO:0043534) | 2.46445252 |
| 151 | transcytosis (GO:0045056) | 2.46086847 |
| 152 | metanephric nephron tubule development (GO:0072234) | 2.45842101 |
| 153 | metanephric tubule development (GO:0072170) | 2.45842101 |
| 154 | regulation of cholesterol esterification (GO:0010872) | 2.45705873 |
| 155 | endothelial cell morphogenesis (GO:0001886) | 2.45696257 |
| 156 | negative regulation of activin receptor signaling pathway (GO:0032926) | 2.44930948 |
| 157 | positive regulation of p38MAPK cascade (GO:1900745) | 2.44905454 |
| 158 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.44062754 |
| 159 | imidazole-containing compound metabolic process (GO:0052803) | 2.43920174 |
| 160 | negative regulation of cholesterol transport (GO:0032375) | 2.43298998 |
| 161 | negative regulation of sterol transport (GO:0032372) | 2.43298998 |
| 162 | response to BMP (GO:0071772) | 2.43251757 |
| 163 | cellular response to BMP stimulus (GO:0071773) | 2.43251757 |
| 164 | midgut development (GO:0007494) | 2.43250669 |
| 165 | extracellular matrix assembly (GO:0085029) | 2.43129925 |
| 166 | exogenous drug catabolic process (GO:0042738) | 2.42935128 |
| 167 | smooth muscle tissue development (GO:0048745) | 2.40198334 |
| 168 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.40133045 |
| 169 | amyloid precursor protein metabolic process (GO:0042982) | 2.39670670 |
| 170 | cellular response to epinephrine stimulus (GO:0071872) | 2.38908743 |
| 171 | multicellular organismal water homeostasis (GO:0050891) | 2.38198514 |
| 172 | regulation of water loss via skin (GO:0033561) | 2.36958663 |
| 173 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.35650253 |
| 174 | positive regulation of metanephros development (GO:0072216) | 2.35600599 |
| 175 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.34251845 |
| 176 | cellular response to antibiotic (GO:0071236) | 2.30921044 |
| 177 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.30643024 |
| 178 | angiogenesis involved in wound healing (GO:0060055) | 2.30501527 |
| 179 | complement activation (GO:0006956) | 2.30071926 |
| 180 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 2.29057512 |
| 181 | fibril organization (GO:0097435) | 2.25563675 |
| 182 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.25087337 |
| 183 | establishment of skin barrier (GO:0061436) | 2.24601701 |
| 184 | regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 2.24221701 |
| 185 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.23417511 |
| 186 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.23381850 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.14025039 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.13202792 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.89268180 |
| 4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.43349849 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.41148016 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.31385687 |
| 7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.23281772 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.99844518 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.98497146 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.65060545 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.60089816 |
| 12 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.54172883 |
| 13 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.27938734 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.21269387 |
| 15 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.17631071 |
| 16 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.97144837 |
| 17 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.88023878 |
| 18 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.86761736 |
| 19 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.85809652 |
| 20 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.80584442 |
| 21 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.79193523 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.76587683 |
| 23 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.76210712 |
| 24 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.73923088 |
| 25 | CJUN_26792858_Chip-Seq_BT549_Human | 1.70730111 |
| 26 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.65223974 |
| 27 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.60733687 |
| 28 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.58460435 |
| 29 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.57792163 |
| 30 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.56864271 |
| 31 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.56807352 |
| 32 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.55566298 |
| 33 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.55212635 |
| 34 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.50363577 |
| 35 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.48717894 |
| 36 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.48331648 |
| 37 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.48026893 |
| 38 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.47895049 |
| 39 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.47895049 |
| 40 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.45964790 |
| 41 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.45522200 |
| 42 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.44221528 |
| 43 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.44063268 |
| 44 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.41917490 |
| 45 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.41917490 |
| 46 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.41917490 |
| 47 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.41871778 |
| 48 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.41175420 |
| 49 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.35653259 |
| 50 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.35172337 |
| 51 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.33877373 |
| 52 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.33817303 |
| 53 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.33817303 |
| 54 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.33699118 |
| 55 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.31984037 |
| 56 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.30955661 |
| 57 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.24148938 |
| 58 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.23859214 |
| 59 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.23619051 |
| 60 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22640996 |
| 61 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.22151619 |
| 62 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.20409807 |
| 63 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.19298671 |
| 64 | KDM2B_26808549_Chip-Seq_K562_Human | 1.18880500 |
| 65 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.16276706 |
| 66 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.15989741 |
| 67 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.14784859 |
| 68 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.14085824 |
| 69 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.13192324 |
| 70 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.12932430 |
| 71 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.10981933 |
| 72 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.09354116 |
| 73 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.08779201 |
| 74 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08471702 |
| 75 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.07299491 |
| 76 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06417684 |
| 77 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.06225942 |
| 78 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.05345293 |
| 79 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.05138534 |
| 80 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04645217 |
| 81 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.04633343 |
| 82 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04419460 |
| 83 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03061448 |
| 84 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.01560003 |
| 85 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.01448970 |
| 86 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.00647638 |
| 87 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.00647638 |
| 88 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.00054992 |
| 89 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.99400972 |
| 90 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.97810702 |
| 91 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97115974 |
| 92 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.96978729 |
| 93 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.96401570 |
| 94 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.96366162 |
| 95 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.96156832 |
| 96 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.95932102 |
| 97 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.94960639 |
| 98 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.94578886 |
| 99 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.94578886 |
| 100 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.93093524 |
| 101 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92368950 |
| 102 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.91426217 |
| 103 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.91391427 |
| 104 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90862048 |
| 105 | TP53_16413492_ChIP-PET_HCT116_Human | 0.90787433 |
| 106 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.90491057 |
| 107 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.90178305 |
| 108 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.89968687 |
| 109 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.89841785 |
| 110 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89818822 |
| 111 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.88281153 |
| 112 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.87134015 |
| 113 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.86529614 |
| 114 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85868876 |
| 115 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.84884781 |
| 116 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.84817162 |
| 117 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.84076295 |
| 118 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.83781245 |
| 119 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.83701602 |
| 120 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.83414620 |
| 121 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.82393969 |
| 122 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.82380307 |
| 123 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.82143401 |
| 124 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81150108 |
| 125 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.81041235 |
| 126 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.80722232 |
| 127 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.78750229 |
| 128 | RXR_22108803_ChIP-Seq_LS180_Human | 0.78002402 |
| 129 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.77752218 |
| 130 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77449850 |
| 131 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76841412 |
| 132 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.74524142 |
| 133 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.73314311 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.33228429 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.28131110 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 3.45012101 |
| 4 | MP0010368_abnormal_lymphatic_system | 3.33214931 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.18106526 |
| 6 | MP0002138_abnormal_hepatobiliary_system | 3.12875627 |
| 7 | MP0005365_abnormal_bile_salt | 3.01602821 |
| 8 | MP0005409_darkened_coat_color | 3.00104861 |
| 9 | MP0003252_abnormal_bile_duct | 2.90505673 |
| 10 | MP0004272_abnormal_basement_membrane | 2.75267094 |
| 11 | MP0002254_reproductive_system_inflammat | 2.57494944 |
| 12 | MP0004782_abnormal_surfactant_physiolog | 2.42138756 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 2.27357946 |
| 14 | MP0008004_abnormal_stomach_pH | 2.15553996 |
| 15 | MP0001879_abnormal_lymphatic_vessel | 2.12999166 |
| 16 | MP0001958_emphysema | 1.97906524 |
| 17 | MP0010329_abnormal_lipoprotein_level | 1.96766511 |
| 18 | MP0002796_impaired_skin_barrier | 1.88582463 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 1.86075540 |
| 20 | MP0001666_abnormal_nutrient_absorption | 1.85059890 |
| 21 | MP0003724_increased_susceptibility_to | 1.83601936 |
| 22 | MP0003566_abnormal_cell_adhesion | 1.80407092 |
| 23 | MP0003011_delayed_dark_adaptation | 1.75863913 |
| 24 | MP0005083_abnormal_biliary_tract | 1.75549452 |
| 25 | MP0005503_abnormal_tendon_morphology | 1.72314529 |
| 26 | MP0005275_abnormal_skin_tensile | 1.71787831 |
| 27 | MP0010234_abnormal_vibrissa_follicle | 1.69830522 |
| 28 | MP0004019_abnormal_vitamin_homeostasis | 1.66221838 |
| 29 | MP0009384_cardiac_valve_regurgitation | 1.64281130 |
| 30 | MP0002060_abnormal_skin_morphology | 1.58632679 |
| 31 | MP0000566_synostosis | 1.56109024 |
| 32 | MP0000383_abnormal_hair_follicle | 1.54298644 |
| 33 | MP0010030_abnormal_orbit_morphology | 1.49729707 |
| 34 | MP0003453_abnormal_keratinocyte_physiol | 1.48703944 |
| 35 | MP0010678_abnormal_skin_adnexa | 1.48325715 |
| 36 | MP0004084_abnormal_cardiac_muscle | 1.47890662 |
| 37 | MP0003890_abnormal_embryonic-extraembry | 1.46801509 |
| 38 | MP0005332_abnormal_amino_acid | 1.45573584 |
| 39 | MP0000537_abnormal_urethra_morphology | 1.38551644 |
| 40 | MP0008438_abnormal_cutaneous_collagen | 1.37764430 |
| 41 | MP0005508_abnormal_skeleton_morphology | 1.36177502 |
| 42 | MP0009840_abnormal_foam_cell | 1.35923175 |
| 43 | MP0005167_abnormal_blood-brain_barrier | 1.34484531 |
| 44 | MP0002098_abnormal_vibrissa_morphology | 1.34104487 |
| 45 | MP0002933_joint_inflammation | 1.34025374 |
| 46 | MP0009053_abnormal_anal_canal | 1.32816450 |
| 47 | MP0005023_abnormal_wound_healing | 1.31524866 |
| 48 | MP0002127_abnormal_cardiovascular_syste | 1.31450404 |
| 49 | MP0003136_yellow_coat_color | 1.30805950 |
| 50 | MP0003941_abnormal_skin_development | 1.30212200 |
| 51 | MP0002877_abnormal_melanocyte_morpholog | 1.27885888 |
| 52 | MP0000465_gastrointestinal_hemorrhage | 1.27442499 |
| 53 | MP0003195_calcinosis | 1.26576882 |
| 54 | MP0009643_abnormal_urine_homeostasis | 1.26508627 |
| 55 | MP0004233_abnormal_muscle_weight | 1.23956752 |
| 56 | MP0010352_gastrointestinal_tract_polyps | 1.23318025 |
| 57 | MP0001346_abnormal_lacrimal_gland | 1.21585021 |
| 58 | MP0002118_abnormal_lipid_homeostasis | 1.20394622 |
| 59 | MP0001188_hyperpigmentation | 1.19155730 |
| 60 | MP0000579_abnormal_nail_morphology | 1.18285852 |
| 61 | MP0008775_abnormal_heart_ventricle | 1.18122764 |
| 62 | MP0003300_gastrointestinal_ulcer | 1.17289365 |
| 63 | MP0005084_abnormal_gallbladder_morpholo | 1.16767826 |
| 64 | MP0003868_abnormal_feces_composition | 1.14469583 |
| 65 | MP0002295_abnormal_pulmonary_circulatio | 1.14459642 |
| 66 | MP0005330_cardiomyopathy | 1.14028295 |
| 67 | MP0003283_abnormal_digestive_organ | 1.13207133 |
| 68 | MP0000609_abnormal_liver_physiology | 1.12959930 |
| 69 | MP0002998_abnormal_bone_remodeling | 1.11550092 |
| 70 | MP0005501_abnormal_skin_physiology | 1.11421040 |
| 71 | MP0000767_abnormal_smooth_muscle | 1.11299937 |
| 72 | MP0009764_decreased_sensitivity_to | 1.10801609 |
| 73 | MP0003806_abnormal_nucleotide_metabolis | 1.10271327 |
| 74 | MP0005623_abnormal_meninges_morphology | 1.09052308 |
| 75 | MP0003091_abnormal_cell_migration | 1.09051367 |
| 76 | MP0002925_abnormal_cardiovascular_devel | 1.04269093 |
| 77 | MP0005164_abnormal_response_to | 1.02759979 |
| 78 | MP0001614_abnormal_blood_vessel | 1.01083631 |
| 79 | MP0001851_eye_inflammation | 1.00376794 |
| 80 | MP0001216_abnormal_epidermal_layer | 0.98966859 |
| 81 | MP0000467_abnormal_esophagus_morphology | 0.98622399 |
| 82 | MP0001881_abnormal_mammary_gland | 0.97684889 |
| 83 | MP0004215_abnormal_myocardial_fiber | 0.96952852 |
| 84 | MP0002932_abnormal_joint_morphology | 0.96432398 |
| 85 | MP0005319_abnormal_enzyme/_coenzyme | 0.94119257 |
| 86 | MP0002136_abnormal_kidney_physiology | 0.93097724 |
| 87 | MP0000462_abnormal_digestive_system | 0.92160188 |
| 88 | MP0000751_myopathy | 0.92104224 |
| 89 | MP0005076_abnormal_cell_differentiation | 0.91895240 |
| 90 | MP0004036_abnormal_muscle_relaxation | 0.90743473 |
| 91 | MP0000516_abnormal_urinary_system | 0.89858972 |
| 92 | MP0005367_renal/urinary_system_phenotyp | 0.89858972 |
| 93 | MP0003385_abnormal_body_wall | 0.89163533 |
| 94 | MP0001756_abnormal_urination | 0.88077595 |
| 95 | MP0005666_abnormal_adipose_tissue | 0.87172784 |
| 96 | MP0000647_abnormal_sebaceous_gland | 0.86758254 |
| 97 | MP0000249_abnormal_blood_vessel | 0.86113981 |
| 98 | MP0002168_other_aberrant_phenotype | 0.85925147 |
| 99 | MP0005408_hypopigmentation | 0.85708968 |
| 100 | MP0001664_abnormal_digestion | 0.84250822 |
| 101 | MP0006138_congestive_heart_failure | 0.83598389 |
| 102 | MP0000013_abnormal_adipose_tissue | 0.83226203 |
| 103 | MP0005166_decreased_susceptibility_to | 0.82409223 |
| 104 | MP0003279_aneurysm | 0.82181645 |
| 105 | MP0005390_skeleton_phenotype | 0.82141915 |
| 106 | MP0004264_abnormal_extraembryonic_tissu | 0.81163922 |
| 107 | MP0002132_abnormal_respiratory_system | 0.80508234 |
| 108 | MP0005165_increased_susceptibility_to | 0.80121779 |
| 109 | MP0010630_abnormal_cardiac_muscle | 0.79971596 |
| 110 | MP0005595_abnormal_vascular_smooth | 0.79114528 |
| 111 | MP0005647_abnormal_sex_gland | 0.78718723 |
| 112 | MP0001873_stomach_inflammation | 0.77627994 |
| 113 | MP0003045_fibrosis | 0.77360584 |
| 114 | MP0000627_abnormal_mammary_gland | 0.77169051 |
| 115 | MP0006054_spinal_hemorrhage | 0.77045991 |
| 116 | MP0004510_myositis | 0.77012119 |
| 117 | MP0004858_abnormal_nervous_system | 0.76893316 |
| 118 | MP0005670_abnormal_white_adipose | 0.76654876 |
| 119 | MP0005388_respiratory_system_phenotype | 0.76475105 |
| 120 | MP0002133_abnormal_respiratory_system | 0.76475105 |
| 121 | MP0010771_integument_phenotype | 0.76056810 |
| 122 | MP0000762_abnormal_tongue_morphology | 0.75577782 |
| 123 | MP0000538_abnormal_urinary_bladder | 0.75479745 |
| 124 | MP0005375_adipose_tissue_phenotype | 0.75413911 |
| 125 | MP0000377_abnormal_hair_follicle | 0.73990038 |
| 126 | MP0005248_abnormal_Harderian_gland | 0.73475236 |
| 127 | MP0000534_abnormal_ureter_morphology | 0.70952507 |
| 128 | MP0002972_abnormal_cardiac_muscle | 0.70446410 |
| 129 | MP0003638_abnormal_response/metabolism_ | 0.69983251 |
| 130 | MP0001849_ear_inflammation | 0.69272310 |
| 131 | MP0004883_abnormal_blood_vessel | 0.68707248 |
| 132 | MP0000681_abnormal_thyroid_gland | 0.68321246 |
| 133 | MP0002928_abnormal_bile_duct | 0.67789622 |
| 134 | MP0002135_abnormal_kidney_morphology | 0.67600127 |
| 135 | MP0001177_atelectasis | 0.67575570 |
| 136 | MP0002876_abnormal_thyroid_physiology | 0.67394114 |
| 137 | MP0002896_abnormal_bone_mineralization | 0.67191000 |
| 138 | MP0005220_abnormal_exocrine_pancreas | 0.67018650 |
| 139 | MP0000427_abnormal_hair_cycle | 0.66859560 |
| 140 | MP0010155_abnormal_intestine_physiology | 0.66163982 |
| 141 | MP0009780_abnormal_chondrocyte_physiolo | 0.65926028 |
| 142 | MP0004085_abnormal_heartbeat | 0.65326091 |
| 143 | MP0002128_abnormal_blood_circulation | 0.65262014 |
| 144 | MP0003828_pulmonary_edema | 0.65121914 |
| 145 | MP0005385_cardiovascular_system_phenoty | 0.64839913 |
| 146 | MP0001544_abnormal_cardiovascular_syste | 0.64839913 |
| 147 | MP0001175_abnormal_lung_morphology | 0.63276682 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.42534836 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 4.21754800 |
| 3 | Onycholysis (HP:0001806) | 4.12825782 |
| 4 | Interstitial pulmonary disease (HP:0006530) | 4.09094345 |
| 5 | Esophageal varix (HP:0002040) | 3.99502232 |
| 6 | Complement deficiency (HP:0004431) | 3.97319226 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.95653886 |
| 8 | Right ventricular cardiomyopathy (HP:0011663) | 3.86421816 |
| 9 | Xanthomatosis (HP:0000991) | 3.78020393 |
| 10 | Prolonged partial thromboplastin time (HP:0003645) | 3.67057380 |
| 11 | Atrophic scars (HP:0001075) | 3.55678219 |
| 12 | Focal segmental glomerulosclerosis (HP:0000097) | 3.45785002 |
| 13 | Vascular calcification (HP:0004934) | 3.44389378 |
| 14 | Polycythemia (HP:0001901) | 3.42043950 |
| 15 | Joint hemorrhage (HP:0005261) | 3.36682484 |
| 16 | Hyperactive renin-angiotensin system (HP:0000841) | 3.36385795 |
| 17 | Milia (HP:0001056) | 3.34738490 |
| 18 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.26494626 |
| 19 | Cardiovascular calcification (HP:0011915) | 3.25947904 |
| 20 | Potter facies (HP:0002009) | 3.08239219 |
| 21 | Facial shape deformation (HP:0011334) | 3.08239219 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.05841140 |
| 23 | Abnormality of complement system (HP:0005339) | 3.04451347 |
| 24 | Protrusio acetabuli (HP:0003179) | 3.01070459 |
| 25 | Glomerulosclerosis (HP:0000096) | 2.99687441 |
| 26 | Cerebral aneurysm (HP:0004944) | 2.95875277 |
| 27 | Abnormality of the common coagulation pathway (HP:0010990) | 2.95726064 |
| 28 | Nephritis (HP:0000123) | 2.93314897 |
| 29 | Fragile nails (HP:0001808) | 2.92178611 |
| 30 | Ureteral duplication (HP:0000073) | 2.86903593 |
| 31 | Arterial tortuosity (HP:0005116) | 2.82618579 |
| 32 | Vascular tortuosity (HP:0004948) | 2.79658481 |
| 33 | Hyperlipoproteinemia (HP:0010980) | 2.78457368 |
| 34 | Anomalous pulmonary venous return (HP:0010772) | 2.78420365 |
| 35 | Hematochezia (HP:0002573) | 2.72834906 |
| 36 | Plantar hyperkeratosis (HP:0007556) | 2.72250385 |
| 37 | Abnormality of the pulmonary veins (HP:0011718) | 2.70862109 |
| 38 | Abnormal pancreas size (HP:0012094) | 2.68263678 |
| 39 | Myocardial infarction (HP:0001658) | 2.67653817 |
| 40 | Hypoalphalipoproteinemia (HP:0003233) | 2.66665091 |
| 41 | Pulmonary artery stenosis (HP:0004415) | 2.64608984 |
| 42 | Epidermoid cyst (HP:0200040) | 2.64458427 |
| 43 | Aortic aneurysm (HP:0004942) | 2.63469487 |
| 44 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.63422005 |
| 45 | Single umbilical artery (HP:0001195) | 2.63422005 |
| 46 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.63422005 |
| 47 | Neonatal death (HP:0003811) | 2.61122003 |
| 48 | Abnormality of the intrinsic pathway (HP:0010989) | 2.61109202 |
| 49 | Bronchomalacia (HP:0002780) | 2.60141392 |
| 50 | Large earlobe (HP:0009748) | 2.59583288 |
| 51 | Hypobetalipoproteinemia (HP:0003563) | 2.58028377 |
| 52 | Alopecia of scalp (HP:0002293) | 2.54800152 |
| 53 | Spontaneous hematomas (HP:0007420) | 2.52083209 |
| 54 | Rhizomelia (HP:0008905) | 2.51623485 |
| 55 | Aortic regurgitation (HP:0001659) | 2.48621729 |
| 56 | Congenital malformation of the right heart (HP:0011723) | 2.47913748 |
| 57 | Double outlet right ventricle (HP:0001719) | 2.47913748 |
| 58 | Respiratory distress (HP:0002098) | 2.45763454 |
| 59 | Hypolipoproteinemia (HP:0010981) | 2.45685062 |
| 60 | Vertebral arch anomaly (HP:0008438) | 2.45501889 |
| 61 | Patent foramen ovale (HP:0001655) | 2.42842284 |
| 62 | Fat malabsorption (HP:0002630) | 2.40610087 |
| 63 | Cervical subluxation (HP:0003308) | 2.37005485 |
| 64 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.36929253 |
| 65 | Osteolytic defects of the hand bones (HP:0009699) | 2.36929253 |
| 66 | Pulmonary hypertension (HP:0002092) | 2.32329136 |
| 67 | Scotoma (HP:0000575) | 2.30593691 |
| 68 | Tubulointerstitial fibrosis (HP:0005576) | 2.29737982 |
| 69 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.29052327 |
| 70 | Small epiphyses (HP:0010585) | 2.24948007 |
| 71 | Hydroxyprolinuria (HP:0003080) | 2.20810278 |
| 72 | Abnormality of proline metabolism (HP:0010907) | 2.20810278 |
| 73 | Broad face (HP:0000283) | 2.19737115 |
| 74 | Aortic dissection (HP:0002647) | 2.19149054 |
| 75 | Conjugated hyperbilirubinemia (HP:0002908) | 2.18006681 |
| 76 | Ulnar bowing (HP:0003031) | 2.17168378 |
| 77 | Premature rupture of membranes (HP:0001788) | 2.16294898 |
| 78 | Wormian bones (HP:0002645) | 2.15286893 |
| 79 | Menorrhagia (HP:0000132) | 2.14907991 |
| 80 | Hemorrhage of the eye (HP:0011885) | 2.13914706 |
| 81 | Increased mean platelet volume (HP:0011877) | 2.13517371 |
| 82 | Aortic valve stenosis (HP:0001650) | 2.13108544 |
| 83 | Broad metatarsal (HP:0001783) | 2.12557302 |
| 84 | Abnormality of carpal bone ossification (HP:0006257) | 2.12274295 |
| 85 | Malnutrition (HP:0004395) | 2.11682130 |
| 86 | Abnormal hemoglobin (HP:0011902) | 2.10132912 |
| 87 | Limited hip movement (HP:0008800) | 2.09601675 |
| 88 | Short clavicles (HP:0000894) | 2.09249638 |
| 89 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.06491266 |
| 90 | Amyloidosis (HP:0011034) | 2.05950069 |
| 91 | Vertebral clefting (HP:0008428) | 2.05425731 |
| 92 | Glomerulonephritis (HP:0000099) | 2.04659805 |
| 93 | Choroideremia (HP:0001139) | 2.03549517 |
| 94 | Abnormality of purine metabolism (HP:0004352) | 2.03405501 |
| 95 | Hypoglycemic coma (HP:0001325) | 2.03234418 |
| 96 | Visceral angiomatosis (HP:0100761) | 2.02553293 |
| 97 | Relative macrocephaly (HP:0004482) | 2.01119458 |
| 98 | Gout (HP:0001997) | 2.00864333 |
| 99 | Short nail (HP:0001799) | 2.00391664 |
| 100 | Persistence of primary teeth (HP:0006335) | 1.99517799 |
| 101 | Flat acetabular roof (HP:0003180) | 1.99376879 |
| 102 | Hypercholesterolemia (HP:0003124) | 1.98888258 |
| 103 | Shallow orbits (HP:0000586) | 1.98352665 |
| 104 | Renal salt wasting (HP:0000127) | 1.98205081 |
| 105 | Syncope (HP:0001279) | 1.98151899 |
| 106 | Abnormal ossification of hand bones (HP:0005921) | 1.97569503 |
| 107 | Thick nail (HP:0001805) | 1.96354042 |
| 108 | Hyperammonemia (HP:0001987) | 1.95749606 |
| 109 | Abnormality of the aortic arch (HP:0012303) | 1.95234738 |
| 110 | Hyperglycinuria (HP:0003108) | 1.95220879 |
| 111 | Hyperkalemia (HP:0002153) | 1.95220208 |
| 112 | Abnormality of chloride homeostasis (HP:0011422) | 1.94858002 |
| 113 | Portal hypertension (HP:0001409) | 1.93782400 |
| 114 | Ectopia lentis (HP:0001083) | 1.93104333 |
| 115 | Systemic lupus erythematosus (HP:0002725) | 1.93092753 |
| 116 | Lymphangioma (HP:0100764) | 1.92869623 |
| 117 | Aneurysm (HP:0002617) | 1.92165842 |
| 118 | Aplasia cutis congenita (HP:0001057) | 1.91459164 |
| 119 | Aplasia/Hypoplasia of the clavicles (HP:0006710) | 1.91045937 |
| 120 | Acanthosis nigricans (HP:0000956) | 1.89976771 |
| 121 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.89755367 |
| 122 | Nail dystrophy (HP:0008404) | 1.87624424 |
| 123 | Abnormality of nucleobase metabolism (HP:0010932) | 1.86532212 |
| 124 | Coronal craniosynostosis (HP:0004440) | 1.86344396 |
| 125 | Hepatocellular carcinoma (HP:0001402) | 1.86189336 |
| 126 | Ventricular tachycardia (HP:0004756) | 1.85526202 |
| 127 | Hyperaldosteronism (HP:0000859) | 1.85463150 |
| 128 | Abnormality of the umbilical cord (HP:0010881) | 1.84958970 |
| 129 | Abnormal vertebral ossification (HP:0100569) | 1.84436805 |
| 130 | Hypoplasia of dental enamel (HP:0006297) | 1.84308917 |
| 131 | Rectal prolapse (HP:0002035) | 1.84077178 |
| 132 | Hemangiomatosis (HP:0007461) | 1.83852954 |
| 133 | Stenosis of the external auditory canal (HP:0000402) | 1.83331429 |
| 134 | Mitral valve prolapse (HP:0001634) | 1.82747096 |
| 135 | Oligodontia (HP:0000677) | 1.82672173 |
| 136 | Abnormality of the right ventricle (HP:0001707) | 1.82586335 |
| 137 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.81377663 |
| 138 | Mitral stenosis (HP:0001718) | 1.81308770 |
| 139 | Abnormal hand bone ossification (HP:0010660) | 1.80591468 |
| 140 | Hypoplastic nipples (HP:0002557) | 1.80267983 |
| 141 | Abnormal platelet volume (HP:0011876) | 1.80036470 |
| 142 | Decreased circulating renin level (HP:0003351) | 1.79317691 |
| 143 | Stroke (HP:0001297) | 1.79309237 |
| 144 | Ileus (HP:0002595) | 1.78729793 |
| 145 | Abnormality of the dental root (HP:0006486) | 1.78021429 |
| 146 | Taurodontia (HP:0000679) | 1.78021429 |
| 147 | Abnormality of permanent molar morphology (HP:0011071) | 1.78021429 |
| 148 | Fragile skin (HP:0001030) | 1.77525187 |
| 149 | Distal lower limb muscle weakness (HP:0009053) | 1.77129353 |
| 150 | Joint laxity (HP:0001388) | 1.76845933 |
| 151 | Tachypnea (HP:0002789) | 1.75974995 |
| 152 | Abnormality of glycine metabolism (HP:0010895) | 1.75601473 |
| 153 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.75601473 |
| 154 | Abnormality of molar (HP:0011077) | 1.75106398 |
| 155 | Abnormality of molar morphology (HP:0011070) | 1.75106398 |
| 156 | Abnormality of the dental pulp (HP:0006479) | 1.75028187 |
| 157 | Mesangial abnormality (HP:0001966) | 1.74962481 |
| 158 | Blue sclerae (HP:0000592) | 1.74920470 |
| 159 | Wrist flexion contracture (HP:0001239) | 1.74795503 |
| 160 | Spinal rigidity (HP:0003306) | 1.74716465 |
| 161 | Hematuria (HP:0000790) | 1.73030375 |
| 162 | Long toe (HP:0010511) | 1.72930881 |
| 163 | Overgrowth (HP:0001548) | 1.71830061 |
| 164 | Short humerus (HP:0005792) | 1.71760880 |
| 165 | Striae distensae (HP:0001065) | 1.71086867 |
| 166 | Steatorrhea (HP:0002570) | 1.70463075 |
| 167 | Hyperglycinemia (HP:0002154) | 1.70197533 |
| 168 | Camptodactyly of toe (HP:0001836) | 1.69830050 |
| 169 | Abnormality of the hepatic vasculature (HP:0006707) | 1.69634472 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 4.11317849 |
| 2 | EPHA2 | 3.76345782 |
| 3 | LMTK2 | 3.28893987 |
| 4 | TGFBR2 | 3.07073011 |
| 5 | LATS1 | 3.06513304 |
| 6 | EPHB2 | 2.79336459 |
| 7 | ERN1 | 2.76260059 |
| 8 | PRPF4B | 2.60294942 |
| 9 | FGFR4 | 2.49941798 |
| 10 | KDR | 2.41831885 |
| 11 | MST1R | 2.35904306 |
| 12 | FER | 2.25192892 |
| 13 | FRK | 2.24910414 |
| 14 | EPHB1 | 2.19455840 |
| 15 | MAP3K3 | 2.15914257 |
| 16 | SIK1 | 2.12074545 |
| 17 | MST4 | 2.01142743 |
| 18 | MYLK | 1.98932713 |
| 19 | TTN | 1.89247531 |
| 20 | PTK6 | 1.85394610 |
| 21 | EPHA3 | 1.77949417 |
| 22 | PTK2 | 1.77070909 |
| 23 | INSRR | 1.74384910 |
| 24 | RIPK1 | 1.70946065 |
| 25 | STK10 | 1.65300457 |
| 26 | MAP3K6 | 1.52956862 |
| 27 | FGFR2 | 1.48703186 |
| 28 | NME1 | 1.47215861 |
| 29 | LRRK2 | 1.47205018 |
| 30 | PDK2 | 1.44273378 |
| 31 | WNK4 | 1.43119033 |
| 32 | ERBB4 | 1.39860392 |
| 33 | STK38L | 1.36308442 |
| 34 | TRIB3 | 1.34434836 |
| 35 | MAPK15 | 1.31204182 |
| 36 | MET | 1.30577146 |
| 37 | STK38 | 1.21210041 |
| 38 | MAP3K14 | 1.19024507 |
| 39 | MAP3K2 | 1.16564849 |
| 40 | PDGFRA | 1.16059838 |
| 41 | GRK1 | 1.10510295 |
| 42 | IRAK3 | 1.09628619 |
| 43 | FGFR3 | 1.09598635 |
| 44 | ACVR1B | 1.09330515 |
| 45 | DDR2 | 1.08212272 |
| 46 | PIK3CG | 1.07561258 |
| 47 | NUAK1 | 1.04855440 |
| 48 | PAK4 | 1.04540332 |
| 49 | PRKD2 | 1.02826405 |
| 50 | TGFBR1 | 1.01166975 |
| 51 | PIK3CA | 1.01065318 |
| 52 | PAK2 | 0.98319694 |
| 53 | STK3 | 0.97501319 |
| 54 | RPS6KA2 | 0.97185210 |
| 55 | MAP2K2 | 0.92277997 |
| 56 | ILK | 0.91933926 |
| 57 | NEK9 | 0.91505105 |
| 58 | MAPK7 | 0.90948873 |
| 59 | MARK2 | 0.90218991 |
| 60 | CSK | 0.90180054 |
| 61 | BCKDK | 0.89274372 |
| 62 | TAOK3 | 0.89198747 |
| 63 | CAMK1D | 0.89078101 |
| 64 | DMPK | 0.88891895 |
| 65 | TESK1 | 0.84296079 |
| 66 | MAP3K12 | 0.83656015 |
| 67 | ICK | 0.82348303 |
| 68 | GSK3A | 0.82293303 |
| 69 | NTRK1 | 0.82050133 |
| 70 | ERBB2 | 0.81875944 |
| 71 | TRPM7 | 0.79341652 |
| 72 | JAK1 | 0.79094049 |
| 73 | AKT3 | 0.78442013 |
| 74 | MATK | 0.77010754 |
| 75 | BMX | 0.76270905 |
| 76 | MAP3K7 | 0.73815069 |
| 77 | TAOK2 | 0.72769160 |
| 78 | MAP2K3 | 0.69776531 |
| 79 | TYK2 | 0.67716633 |
| 80 | STK39 | 0.67531142 |
| 81 | MAP2K1 | 0.67433095 |
| 82 | PDGFRB | 0.65140346 |
| 83 | RPS6KC1 | 0.64847432 |
| 84 | RPS6KL1 | 0.64847432 |
| 85 | CDK6 | 0.62677630 |
| 86 | MELK | 0.61745869 |
| 87 | NLK | 0.61643823 |
| 88 | ROCK2 | 0.61476061 |
| 89 | PRKG2 | 0.60344429 |
| 90 | PRKD1 | 0.60063220 |
| 91 | MAPKAPK3 | 0.59040628 |
| 92 | ZAK | 0.58385231 |
| 93 | CHUK | 0.58153467 |
| 94 | LATS2 | 0.57693753 |
| 95 | PAK3 | 0.57655891 |
| 96 | PRKAA2 | 0.57553870 |
| 97 | PDPK1 | 0.56551927 |
| 98 | ROCK1 | 0.55035310 |
| 99 | HIPK2 | 0.53092073 |
| 100 | MAPK12 | 0.52562835 |
| 101 | EGFR | 0.50978692 |
| 102 | BMPR1B | 0.50855599 |
| 103 | MAP3K1 | 0.50830453 |
| 104 | DYRK1B | 0.49559328 |
| 105 | CDK9 | 0.49123479 |
| 106 | RPS6KA6 | 0.48933839 |
| 107 | FGFR1 | 0.48892268 |
| 108 | CAMK1G | 0.48764154 |
| 109 | TBK1 | 0.47710078 |
| 110 | ZAP70 | 0.47640009 |
| 111 | PKN2 | 0.47617005 |
| 112 | SGK3 | 0.45008983 |
| 113 | ABL2 | 0.44966208 |
| 114 | IGF1R | 0.44938569 |
| 115 | PTK2B | 0.44020214 |
| 116 | RPS6KA4 | 0.43780377 |
| 117 | MAPK3 | 0.43478421 |
| 118 | SGK2 | 0.40843977 |
| 119 | PRKCE | 0.40521228 |
| 120 | STK24 | 0.39786575 |
| 121 | NEK6 | 0.39654954 |
| 122 | IRAK1 | 0.38447417 |
| 123 | JAK2 | 0.38314467 |
| 124 | ABL1 | 0.37534846 |
| 125 | MTOR | 0.37336243 |
| 126 | PRKD3 | 0.37193146 |
| 127 | RET | 0.35605905 |
| 128 | CAMK2G | 0.35203741 |
| 129 | INSR | 0.34942986 |
| 130 | IKBKE | 0.34765181 |
| 131 | MAPK1 | 0.34473257 |
| 132 | CAMK4 | 0.34454223 |
| 133 | SRC | 0.34078706 |
| 134 | SGK223 | 0.32036632 |
| 135 | SGK494 | 0.32036632 |
| 136 | TNIK | 0.31575824 |
| 137 | MAPKAPK2 | 0.30619330 |
| 138 | RPS6KB2 | 0.29505767 |
| 139 | CDC42BPA | 0.27698365 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.31970986 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.93181356 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.82381273 |
| 4 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.57254931 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.51097253 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.44774212 |
| 7 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.34843552 |
| 8 | Histidine metabolism_Homo sapiens_hsa00340 | 2.21113130 |
| 9 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.19205914 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.17934692 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.08677894 |
| 12 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.08506777 |
| 13 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.00871289 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.98596695 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88271642 |
| 16 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.85809447 |
| 17 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.83569365 |
| 18 | Retinol metabolism_Homo sapiens_hsa00830 | 1.77944879 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.75964173 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.74934376 |
| 21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.67485398 |
| 22 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.61377567 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.60726716 |
| 24 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.59425888 |
| 25 | Bile secretion_Homo sapiens_hsa04976 | 1.54065237 |
| 26 | Peroxisome_Homo sapiens_hsa04146 | 1.52670029 |
| 27 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.48417917 |
| 28 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.47245607 |
| 29 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.45081644 |
| 30 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.44653133 |
| 31 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.43049262 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.42760881 |
| 33 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.39018146 |
| 34 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.37685500 |
| 35 | ABC transporters_Homo sapiens_hsa02010 | 1.32760830 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.32053372 |
| 37 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.30734592 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.25907333 |
| 39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.23032703 |
| 40 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.19304042 |
| 41 | Adherens junction_Homo sapiens_hsa04520 | 1.17403094 |
| 42 | Focal adhesion_Homo sapiens_hsa04510 | 1.17374763 |
| 43 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.17174758 |
| 44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.15248576 |
| 45 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.11223374 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.09042850 |
| 47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.07822588 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.05919641 |
| 49 | Amoebiasis_Homo sapiens_hsa05146 | 1.05806510 |
| 50 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.03870337 |
| 51 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.99997677 |
| 52 | Mineral absorption_Homo sapiens_hsa04978 | 0.98769358 |
| 53 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.98643711 |
| 54 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.97982023 |
| 55 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.97416071 |
| 56 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.92183478 |
| 57 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.90675297 |
| 58 | Renin secretion_Homo sapiens_hsa04924 | 0.89886854 |
| 59 | Other glycan degradation_Homo sapiens_hsa00511 | 0.89773372 |
| 60 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.85604371 |
| 61 | Circadian rhythm_Homo sapiens_hsa04710 | 0.85525380 |
| 62 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.82295050 |
| 63 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.81656031 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81560000 |
| 65 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.80776168 |
| 66 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.80683844 |
| 67 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.79425517 |
| 68 | Galactose metabolism_Homo sapiens_hsa00052 | 0.78485980 |
| 69 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.77381497 |
| 70 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.75999105 |
| 71 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.74599254 |
| 72 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74475756 |
| 73 | Bladder cancer_Homo sapiens_hsa05219 | 0.74226124 |
| 74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.71998865 |
| 75 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69859824 |
| 76 | Lysine degradation_Homo sapiens_hsa00310 | 0.69517831 |
| 77 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69210592 |
| 78 | Thyroid cancer_Homo sapiens_hsa05216 | 0.68670598 |
| 79 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.68448611 |
| 80 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.67972687 |
| 81 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.67812129 |
| 82 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.67472849 |
| 83 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.65816082 |
| 84 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.65226294 |
| 85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.63388188 |
| 86 | Tight junction_Homo sapiens_hsa04530 | 0.61479813 |
| 87 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60989262 |
| 88 | Pathways in cancer_Homo sapiens_hsa05200 | 0.57932647 |
| 89 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57077902 |
| 90 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.56548238 |
| 91 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.56526734 |
| 92 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.56000855 |
| 93 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.55971886 |
| 94 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.55971411 |
| 95 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54331803 |
| 96 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.53970965 |
| 97 | Melanogenesis_Homo sapiens_hsa04916 | 0.53147601 |
| 98 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.52900847 |
| 99 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.52630071 |
| 100 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52388231 |
| 101 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.50290970 |
| 102 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.49539875 |
| 103 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.49309477 |
| 104 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.49272311 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.49183786 |
| 106 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49051151 |
| 107 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.48713413 |
| 108 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.48249993 |
| 109 | Lysosome_Homo sapiens_hsa04142 | 0.46489590 |
| 110 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.45651276 |
| 111 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.43700993 |
| 112 | Endocytosis_Homo sapiens_hsa04144 | 0.42895005 |
| 113 | Malaria_Homo sapiens_hsa05144 | 0.42134849 |
| 114 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.42077633 |
| 115 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.41789754 |
| 116 | Prion diseases_Homo sapiens_hsa05020 | 0.40183538 |
| 117 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39763529 |
| 118 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.39162722 |
| 119 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.38388476 |
| 120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38332109 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.37595734 |
| 122 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.36941011 |
| 123 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.36633877 |
| 124 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.34840016 |
| 125 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.33718815 |
| 126 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.33439883 |
| 127 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.33332164 |
| 128 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.33161033 |
| 129 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.30703409 |
| 130 | Pertussis_Homo sapiens_hsa05133 | 0.30689816 |
| 131 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.30509794 |
| 132 | Hepatitis C_Homo sapiens_hsa05160 | 0.30025703 |
| 133 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.27095509 |
| 134 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.25586405 |
| 135 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.25436891 |
| 136 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.25388005 |
| 137 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.25211133 |
| 138 | Platelet activation_Homo sapiens_hsa04611 | 0.25029423 |

